James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 228,000 shares at $4.53 ($1.0M) on 2024-05-10, disclosed to the SEC on 2024-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.53 | 83,000 | $376K | 36.4% |
| 2 | $4.54 | 145,000 | $658K | 63.6% |
| Total | $4.54 avg | 228,000 | $1.0M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | SELL | 2024-03-29 | $1.0M | — | Filing → |